Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Balancing the Scales of Opportunity: Ensuring Racial and Ethnic Diversity in the Health Professions.

Institute of Medicine (US) Committee to Increase Minority Participation in the Health Professions; Ein Lewin M, Rice B, editors.

Washington (DC): National Academies Press (US); 1994.

2.

The need to understand IRB deliberations.

Candilis PJ, Lidz CW, Arnold RM.

IRB. 2006 Jan-Feb;28(1):1-5. No abstract available.

PMID:
16680872
4.

The limitations of "vulnerability" as a protection for human research participants.

Levine C, Faden R, Grady C, Hammerschmidt D, Eckenwiler L, Sugarman J; Consortium to Examine Clinical Research Ethics..

Am J Bioeth. 2004 Summer;4(3):44-9.

PMID:
16192138
5.

A survey of IRB process in 68 U.S. hospitals.

Larson E, Bratts T, Zwanziger J, Stone P.

J Nurs Scholarsh. 2004;36(3):260-4.

PMID:
15495496
6.

Oversight of human participants research: identifying problems to evaluate reform proposals.

Emanuel EJ, Wood A, Fleischman A, Bowen A, Getz KA, Grady C, Levine C, Hammerschmidt DE, Faden R, Eckenwiler L, Muse CT, Sugarman J.

Ann Intern Med. 2004 Aug 17;141(4):282-91.

PMID:
15313744
7.
8.

The lead-based paint abatement repair and maintenance study in Baltimore: historic framework and study design.

Pollak J.

J Health Care Law Policy. 2002;6(1):89-108. No abstract available.

PMID:
15017953
9.

Interpretations of 'appropriate' minority inclusion in clinical research.

Corbie-Smith G, Miller WC, Ransohoff DF.

Am J Med. 2004 Feb 15;116(4):249-52.

PMID:
14969653
10.

How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Shah S, Whittle A, Wilfond B, Gensler G, Wendler D.

JAMA. 2004 Jan 28;291(4):476-82.

PMID:
14747505
11.

The effect of lead-based paint hazard remediation on blood lead levels of lead poisoned children in New York City.

Leighton J, Klitzman S, Sedlar S, Matte T, Cohen NL.

Environ Res. 2003 Jul;92(3):182-90.

PMID:
12804514
12.
13.

Financial conflicts of interest in human subjects research: the problem of institutional conflicts.

Barnes M, Florencio PS.

J Law Med Ethics. 2002 Fall;30(3):390-402. No abstract available.

PMID:
12497699
14.

U.S. investigating Johns Hopkins study of lead paint hazard.

Lewin T.

N Y Times Web. 2001 Aug 24:A11. No abstract available.

PMID:
12155620
15.
16.

Reviewing the reviewers: the vague accountability of research ethics committees.

Shaul R.

Crit Care. 2002 Apr;6(2):121-2. Epub 2002 Mar 11. Review.

17.

In defense of the Hopkins Lead Abatement Studies.

Ross LF.

J Law Med Ethics. 2002 Spring;30(1):50-7. No abstract available.

PMID:
11905268
18.

Institutional review boards as an instrument of assessment: research involving human subjects in the U.S.

Gray BH.

Sci Technol Human Values. 1978 Fall;(25):Unknown. No abstract available.

PMID:
11663042
19.

Human subjects. Court rebukes Hopkins for lead paint study.

Kaiser J.

Science. 2001 Aug 31;293(5535):1567-9. No abstract available. Erratum in: Science 2001Sep 14;293(5537):1997.

PMID:
11533449
20.

Minority faculty. New data in chemistry show 'zero' diversity.

Mervis J.

Science. 2001 May 18;292(5520):1291-2. No abstract available. Erratum in: Science 2001 Jun 1;292(5522):1656.

PMID:
11360979

Supplemental Content

Support Center